Group One Trading’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $439K | Sell |
86,853
-272,613
| -76% | -$1.38M | ﹤0.01% | 702 |
|
|
2025
Q1 | $1.9M | Buy |
359,466
+77,762
| +28% | +$411K | 0.01% | 269 |
|
|
2024
Q4 | $1.9M | Buy |
281,704
+91,529
| +48% | +$619K | ﹤0.01% | 340 |
|
|
2024
Q3 | $1.25M | Buy |
190,175
+65,334
| +52% | +$431K | ﹤0.01% | 338 |
|
|
2024
Q2 | $936K | Buy |
+124,841
| New | +$936K | ﹤0.01% | 352 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 2995 |
|
|
2023
Q4 | – | Sell |
-6,229
| Closed | -$47.7K | – | 3103 |
|
|
2023
Q3 | $47.7K | Buy |
+6,229
| New | +$47.7K | ﹤0.01% | 1094 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 3061 |
|
|
2023
Q1 | – | Sell |
-5,471
| Closed | -$42.2K | – | 2984 |
|
|
2022
Q4 | $42.2K | Sell |
5,471
-1,429
| -21% | -$11K | ﹤0.01% | 1132 |
|
|
2022
Q3 | $73K | Buy |
+6,900
| New | +$73K | ﹤0.01% | 1109 |
|